Therapeutic Approach of Primary Bone Tumours by Bisphosphonates

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|27|2981-2987

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.27, 2010-09, pp. : 2981-2987

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic options for primary brain tumours

By  

Inpharma, Vol. 1, Iss. 1373, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Therapeutic benefit of bisphosphonates in the management of prostate cancer-related bone disease

By Dawson Nancy A  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 705-716

Informa Healthcare

Access to resources Recommend Favorite

mTOR Inhibitors (Rapamycin and its Derivatives) and Nitrogen Containing Bisphosphonates: Bi-Functional Compounds for the Treatment of Bone Tumours

By  

Current Medicinal Chemistry, Vol. 14, Iss. 13, 2007-06 ,pp. : 1381-1387

Bentham Science Publishers

Access to resources Recommend Favorite

Bisphosphonates as Treatment of Bone Metastases

By  

Current Pharmaceutical Design, Vol. 16, Iss. 11, 2010-04 ,pp. : 1262-1271

Bentham Science Publishers

Access to resources Recommend Favorite

State of the Art of Biochemical Markers in Metastatic Bone Disease and the Role of Bisphosphonates as Therapeutic Agents

By  

Current Pharmaceutical Analysis, Vol. 1, Iss. 3, 2005-11 ,pp. : 225-241

Bentham Science Publishers

Access to resources Recommend Favorite